Surveillance of Pancreatic Health After Diabetes Diagnosis

Recruiting now · Not applicable

Conditions studied: Diabetes Mellitus, Pancreatic Cancer, Adult

In brief

The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2 diabetes within the last 6 months. Participants will: * attend 3 study visits over 12 months time * provide a blood sample at each study visit * complete an anxiety questionnaire at each visit.

Key facts

Study ID
NCT06803771
Run by
University Hospital Southampton NHS Foundation Trust
People needed
15000
Starts
2025-05-21
Expected to finish
2029-02-01
Last updated by the study team
2026-03-23

Who can join

Age: 50 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.